Topical diacerein for epidermolysis bullosa: A randomized controlled pilot study

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Wally, Verena ^a   Kitzmueller, Sophie ^a   Lagler, Florian ^a   Moder, Angelika ^a   Hitzl, Wolfgang ^a   Wolkersdorfer, Martin ^b   Hofbauer, Peter ^b   Felder, Thomas K ^a   Dornauer, Michael ^a   Diem, Anja ^a   Eiler, Nora ^a   Bauer, Johann W ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b Department of Production   (Austria)

Author keywords

Diacerein; Epidermolysis bullosa; Interleukin 1 ; Keratin 14; Pilot study; Small molecule therapies

Indexed keywords

DIACEREIN; PLACEBO;

ADULT; ARTICLE; BLISTER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; EPIDERMOLYSIS BULLOSA; HUMAN; PILOT STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; BLISTER; CHILD; DOUBLE-BLIND METHOD; EPIDERMOLYSIS BULLOSA SIMPLEX; HUMANS; KERATIN-14; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877068542     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-69     Document Type: Article

References (5)

1. Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Morley SM, D'Alessandro M, Sexton C, Rugg EL, Navsaria H, Shemanko CS, Huber M, Hohl D, Heagerty AI, Leigh IM, Lane EB, Br J Dermatol 2003 149 46 58 10.1046/j.1365-2133.2003.05493.x 12890194 (Pubitemid 36966510)
2. Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. Coulombe PA, Kerns ML, Fuchs E, J Clin Invest 2009 119 1784 1793 10.1172/JCI38177 19587453
3. The pathogenetic role of interleukin-1 beta in severe epidermolysis bullosa simplex. Wally V, Lettner T, Peking P, Peckl-Schmid D, Murauer EM, Hainzl S, Hintner H, Bauer JW, J Invest Dermatol 2013 10.1038/jid.2013.31
4. Diacerhein and rhein reduce the ICE-induced IL-1ß and IL-18 activation in human osteoarthritic cartilage. Moldovan F, Pelletier JP, Jolicoeur FC, Cloutier JM, Martel-Pelletier J, Osteoarthritis Cartilage 2000 8 186 196 10.1053/joca.1999.0289 10806046 (Pubitemid 30304186)
5. Chondroprotective drugs in degenerative joint diseases. Verbruggen G, Rheumatol 2006 45 129 138 (Pubitemid 43160071)